Skip to main content

head congestion plus flu severe PE

NDC 41250-574 · MEIJER DISTRIBUTION INC

FDA lists marketing as ended on 2026-08-31.
Generic nameACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE
Dosage formTABLET, COATED
RouteORAL
Active ingredient(s)ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE
Strength325; 10; 100; 5 mg/1; mg/1; mg/1; mg/1
Pharmacologic classAdrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
Marketing categoryOTC MONOGRAPH DRUG

Packages

41250-574-02 — 2 BLISTER PACK in 1 CARTON (41250-574-02) / 12 TABLET, COATED in 1 BLISTER PACK

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

41250-436 — dextromethorphan hydrobromide, guaifenesin, 41250-446 — dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride, 41250-459 — Acetaminophen, Dextromethorphan HBr, Doxylamine succinate, 41250-484 — Acetaminophen, 41250-494 — dextromethorphan polistirex, 41250-501 — Acetaminophen, 41250-533 — Dextromethorphan HBr and Guaifenesin, 41250-547 — Guaifenesin, Pseudoephedrine HCl, 41250-554 — Acetaminophen, 41250-570 — Acetaminophen, 41250-590 — acetaminophen, 41250-603 — acetaminophen, dextromethorphan hbr, guaifenesin, phenylephrine hcl, 41250-631 — Acetaminophen, 41250-638 — Acetaminophen, Chlorpheniramine maleate, Dextromethorphan HBr, 41250-643 — acetaminophen, dextromethorphan HBr, guaifenesin, phenylephrine HCl, 41250-650 — Acetaminophen, 41250-654 — guaifenesin, 41250-656 — acetaminophen, dextromethorphan Hbr, Phenylephrine HCl, 41250-658 — Acetaminophen, 41250-663 — ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, and PHENYLEPHRINE HYDROCHLORIDE, +5267 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.